Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
This statistic discloses the global revenue of the French pharmaceutical group Ipsen in the specialty medicine category, from 2014 to 2019 (in million euros). In 2019, the sales value of the group in specialty medicine accounted for 2.299 billion euros, compared to 1.924 billion the previous year.
Global revenue of the French pharmaceutical group Ipsen in specialty medicine from 2014 to 2019 (in million euros)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Global revenue in general medicine of the Ipsen group 2014-2019
- Premium Statistic Global revenue of the Ipsen group 2014-2019
- Premium Statistic Global revenue of the Ipsen group 2019, by geographical area
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Premium Statistic Commercial expenses of the Ipsen group 2014-2019
- Premium Statistic Total assets of the Ipsen group 2014-2019
- Premium Statistic Total equity of the Ipsen group 2014-2019
- Premium Statistic Research and development expenditure of the Ipsen group 2014-2019
- Premium Statistic Operating profit of the Ipsen group 2014-2019
- Premium Statistic Consolidated net profit of the Ipsen group 2014-2019
About the region
10
- Basic Statistic Ipsen group sales 2019, by therapeutic area
- Basic Statistic Orphan drug sales worldwide by therapy category 2028
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
- Premium Statistic Top global companies by orphan drug revenues 2023
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Basic Statistic Medication sales of the Ipsen Group 2019
- Premium Statistic Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Premium Statistic Merck & Co.'s top-selling drugs 2023
- Basic Statistic Merck & Co total assets 2009-2023
- Basic Statistic Top drugs based on projected 2024 global sales
Selected statistics
5
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
10
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Basic Statistic Top U.S. oncology products by revenue in 2016
- Premium Statistic Revenue value from biotechnology companies in Germany 2008-2022
- Basic Statistic Top pharmaceutical companies in Sweden by sales 2022
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Premium Statistic R&D expenses of selected Chinese pharma companies 2021-2022
- Basic Statistic Patented drug products annual sales in Canada 1990-2022
- Basic Statistic Antibacterials for systemic use: consumption in Luxembourg 2022
Related statistics
10
- Premium Statistic Turnover of Boiron laboratories abroad 2012-2022
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
- Premium Statistic Revenue of the top ten pharmaceutical companies in France 2021
- Premium Statistic Global turnover of Boiron laboratories 2012-2022
- Premium Statistic Boiron laboratories turnover in France 2022, by region
- Premium Statistic Boiron laboratories' European turnover in 2022, by country
- Premium Statistic Boiron laboratories turnover in 2022, by region
- Premium Statistic Turnover of Boiron laboratories in North America 2022, by country
- Premium Statistic Turnover of the nonproprietary drugs segment of Boiron in 2022, by region
- Premium Statistic Global turnover of Boiron's specialties segment 2022, by region
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Fragrance market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2022, by product type
- Toiletry market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2009-2022
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Sanofi's total assets 2007-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Fragrance market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2022, by product type
- Toiletry market value in Great Britain 2022, by product type
- Skincare market value in Great Britain 2009-2022
Ipsen. (February 13, 2020). Global revenue of the French pharmaceutical group Ipsen in specialty medicine from 2014 to 2019 (in million euros) [Graph]. In Statista. Retrieved May 11, 2024, from https://www.statista.com/statistics/1072683/ipsen-revenue-specialty-medicine-french-company/
Ipsen. "Global revenue of the French pharmaceutical group Ipsen in specialty medicine from 2014 to 2019 (in million euros)." Chart. February 13, 2020. Statista. Accessed May 11, 2024. https://www.statista.com/statistics/1072683/ipsen-revenue-specialty-medicine-french-company/
Ipsen. (2020). Global revenue of the French pharmaceutical group Ipsen in specialty medicine from 2014 to 2019 (in million euros). Statista. Statista Inc.. Accessed: May 11, 2024. https://www.statista.com/statistics/1072683/ipsen-revenue-specialty-medicine-french-company/
Ipsen. "Global Revenue of The French Pharmaceutical Group Ipsen in Specialty Medicine from 2014 to 2019 (in Million Euros)." Statista, Statista Inc., 13 Feb 2020, https://www.statista.com/statistics/1072683/ipsen-revenue-specialty-medicine-french-company/
Ipsen, Global revenue of the French pharmaceutical group Ipsen in specialty medicine from 2014 to 2019 (in million euros) Statista, https://www.statista.com/statistics/1072683/ipsen-revenue-specialty-medicine-french-company/ (last visited May 11, 2024)
Global revenue of the French pharmaceutical group Ipsen in specialty medicine from 2014 to 2019 (in million euros) [Graph], Ipsen, February 13, 2020. [Online]. Available: https://www.statista.com/statistics/1072683/ipsen-revenue-specialty-medicine-french-company/